Meta-analyses Indicate Associations between Neuroendocrine Activation, Deactivation in Neurotrophic and Neuroimaging Markers in Depression after Stroke
Conclusions: Cortisol-lowering therapies and those that increase blood flow and neurotrophic factors represent promising novel therapeutics for depression subtypes and may reduce the risk of depression in stroke patients.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Kate Noonan, Leeanne M. Carey, Sheila G. Crewther Tags: Original Articles Source Type: research
More News: Allergy & Immunology | Biology | Brain | Databases & Libraries | Depression | Hyperactivity | Neurology | Noonan Syndrome | Perfusion | Stroke